Phase 4 N=28 Drug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin
Healthy
Primary: NK-104 AUC — 192.00 ng * h/mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=418 Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
Pulmonary Disease, Chronic Obstructive
Primary: Internal Consistency (IC) of the Shortness of Breath With Daily Activities (SOBDA) Questionnaire in Participants With Chronic Obstructive Pulmonary Disease (COPD)…
Phase 4 N=49 Sinuclean's Treatment Of Sinusitis' Symptoms
Sinusitis
Primary: Presence of Mucus in the Paranasal Sinuses (Outcome Measure Percentage of Patients) — 71; 57; 33 percentage of patients — p=<0.05
Phase 4 N=318 Effectiveness of Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Primary: Number of Patients Who Were Cured — 91; 117 Participants — p=<0.05
Phase 4 N=26 Somatuline Autogel Preference and Health Economy Study
Neuroendocrine Tumour With Carcinoid Symptoms
Primary: Subject Preference for Self or Partner Administration — 10; 12 participants
Phase 4 N=550 A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis
Rhinitis, Allergic, Perennial
Primary: Cumulative Proportion (CU) of Participants (Par.) With an Event, as Measured as a Percentage, for Posterior Subcapsular Opacity (P) — 0.60; 0.88; 1.24; 1.84 Percentage…
Phase 4 N=3,017 Coloplast DialogueStudy
Stoma
Primary: Quality of Life (Scale 0(Worst)-100(Best)) — 1.8 units on a scale — p=<0.0001
Phase 4 N=51 Hybrid Blood Pressure Monitor Validation
Essential Hypertension
Primary: Systolic Blood Pressure Measured by Tested Device. — 144.11 mmHg
Phase 4 N=36 Aspirin Dosing in Diabetic Patients
Type 2 Diabetes Mellitus · Coronary Artery Disease
Primary: Collagen Induced Aggregation — 32 percentage of platelet aggregation
Phase 4 N=168 Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
Acne Vulgaris
Primary: Mean Change From Baseline to Week 2 in the Global Score of the Participant-completed Skindex-29 Quality of Life (QoL) Questionnaire — -4.9; -1.1 scores on a scale…
Phase 4 N=53 Effect of Calcium + Vitamin D Supplementation on Weight Management in Very-low Calcium Consumers
Obesity · Overweight
Primary: Change in Body Weight — -3.9; -3.5 kg — p=0.441
Phase 4 N=62 Pregabalin and Colonic Function
Healthy
Primary: Sensory Threshold for Pain — 45.8; 46.7; 45.0 mm Hg
Phase 4 N=69 Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women
Osteoporosis, Post-menopausal
Primary: Mineralizing Surface/Bone Surface (MS/BS) in the Cancellous Compartment (CC) of Iliac Crest Bone Biopsies at 6 Months — 5.60; 0.16 percentage of surface — p=<0.001
Phase 4 N=36 Co-Axial Micro-Incision Versus Co-Axial Small Incision Cataract Surgery Using the Stellaris Enhancement System
Cataract · Aphakia
Primary: Refractive Stability — 17; 23; 25; 25 Eyes
Phase 4 N=60 Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
Obstructive Sleep Apnea Syndrome
Primary: The Primary Efficacy Variable Was the Mean Apnea-Hypopnea Index (AHI). — 22.33; 18.18; 21.10; 22.71 Apnea + Hypopnea episodes per hour — p=0.009